These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22264190)

  • 1. Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties.
    Kumar G; Hara H; Long C; Shaikh H; Ayares D; Cooper DK; Ezzelarab M
    Cytotherapy; 2012 Apr; 14(4):494-504. PubMed ID: 22264190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically-modified pig mesenchymal stromal cells: xenoantigenicity and effect on human T-cell xenoresponses.
    Ezzelarab M; Ezzelarab C; Wilhite T; Kumar G; Hara H; Ayares D; Cooper DK
    Xenotransplantation; 2011; 18(3):183-95. PubMed ID: 21696448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.
    Li J; Andreyev O; Chen M; Marco M; Iwase H; Long C; Ayares D; Shen Z; Cooper DK; Ezzelarab MB
    Cell Immunol; 2013; 285(1-2):23-30. PubMed ID: 24044963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs.
    Lee W; Hara H; Ezzelarab MB; Iwase H; Bottino R; Long C; Ramsoondar J; Ayares D; Cooper DK
    Xenotransplantation; 2016 Mar; 23(2):137-50. PubMed ID: 26988899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hematologic, biochemical, and coagulation parameters in α1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species.
    Ekser B; Bianchi J; Ball S; Iwase H; Walters A; Ezzelarab M; Veroux M; Gridelli B; Wagner R; Ayares D; Cooper DK
    Xenotransplantation; 2012; 19(6):342-54. PubMed ID: 23145497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A desirable transgenic strategy using GGTA1 endogenous promoter-mediated knock-in for xenotransplantation model.
    Ko N; Shim J; Kim HJ; Lee Y; Park JK; Kwak K; Lee JW; Jin DI; Kim H; Choi K
    Sci Rep; 2022 Jun; 12(1):9611. PubMed ID: 35688851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial study of α1,3-galactosyltransferase gene-knockout/CD46 pig full-thickness corneal xenografts in rhesus monkeys.
    Dong X; Hara H; Wang Y; Wang L; Zhang Y; Cooper DK; Dai Y; Pan Z
    Xenotransplantation; 2017 Jan; 24(1):. PubMed ID: 28054735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial in vitro investigation of the human immune response to corneal cells from genetically engineered pigs.
    Hara H; Koike N; Long C; Piluek J; Roh DS; SundarRaj N; Funderburgh JL; Mizuguchi Y; Isse K; Phelps CJ; Ball SF; Ayares DL; Cooper DK
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5278-86. PubMed ID: 21596821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition.
    Iwase H; Ekser B; Hara H; Phelps C; Ayares D; Cooper DK; Ezzelarab MB
    Xenotransplantation; 2014; 21(1):72-83. PubMed ID: 24188473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells.
    Ezzelarab C; Ayares D; Cooper DK; Ezzelarab MB
    Xenotransplantation; 2012; 19(5):311-6. PubMed ID: 22970807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration?
    Lee W; Long C; Ramsoondar J; Ayares D; Cooper DK; Manji RA; Hara H
    Xenotransplantation; 2016 Sep; 23(5):370-80. PubMed ID: 27511593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors.
    Chen Y; Stewart JM; Gunthart M; Hawthorne WJ; Salvaris EJ; O'Connell PJ; Nottle MB; d'Apice AJ; Cowan PJ; Kearns-Jonker M
    Xenotransplantation; 2014; 21(3):244-53. PubMed ID: 24645827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells.
    Zhang Z; Hara H; Long C; Iwase H; Qi H; Macedo C; Mangiola M; Zeevi A; Ezzelarab M; Ayares D; Cooper DKC; Wijkstrom M
    Transplantation; 2018 May; 102(5):e195-e204. PubMed ID: 29266033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.
    Russell KA; Chow NH; Dukoff D; Gibson TW; LaMarre J; Betts DH; Koch TG
    PLoS One; 2016; 11(12):e0167442. PubMed ID: 27907211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin from alpha 1,3-galactosyltransferase knockout pigs is a xenoantigen.
    Chihara RK; Lutz AJ; Paris LL; Wang ZY; Sidner RA; Heyrman AT; Downey SM; Burlak C; Tector AJ
    J Surg Res; 2013 Oct; 184(2):1123-33. PubMed ID: 23673165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycocalyx dynamics and the inflammatory response of genetically modified porcine endothelial cells.
    Milusev A; Ren J; Despont A; Shaw J; Längin M; Bender M; Abicht JM; Mokelke M; Radan J; Neumann E; Kemter E; Klymiuk N; Ayares D; Wolf E; Reichart B; Sorvillo N; Rieben R
    Xenotransplantation; 2023; 30(5):e12820. PubMed ID: 37735958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.
    Li J; Ezzelarab MB; Ayares D; Cooper DK
    Stem Cell Rev Rep; 2014 Feb; 10(1):79-85. PubMed ID: 24142483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased human complement pathway regulatory protein gene dose is associated with increased endothelial expression and prolonged survival during ex-vivo perfusion of GTKO pig lungs with human blood.
    Chaban R; McGrath G; Habibabady Z; Rosales I; Burdorf L; Ayares DL; Rybak E; Zhang T; Harris DG; Dahi S; Ali F; Parsell DM; Braileanu G; Cheng X; Sievert E; Phelps C; Azimzadeh AM; Pierson RN
    Xenotransplantation; 2023; 30(4):e12812. PubMed ID: 37504492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
    Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
    Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple genetically modified GTKO/hCD46/HLA-E/hβ2-mg porcine hearts are protected from complement activation and natural killer cell infiltration during ex vivo perfusion with human blood.
    Abicht JM; Sfriso R; Reichart B; Längin M; Gahle K; Puga Yung GL; Seebach JD; Rieben R; Ayares D; Wolf E; Klymiuk N; Baehr A; Kind A; Mayr T; Bauer A
    Xenotransplantation; 2018 Sep; 25(5):e12390. PubMed ID: 29536572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.